Novartis AG Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes
Novartis AG (NVSEF) reported Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes of -$600.00 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-04.
Financial Statements › Notes
ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges · last filed 2026-02-04
- Novartis AG increase decrease in cash and cash equivalents before effect of exchange rate changes for the quarter ending 2025-06-30 was -$792.00M.
- Novartis AG increase decrease in cash and cash equivalents before effect of exchange rate changes for the quarter ending 2024-06-30 was -$1.53B.
- Novartis AG increase decrease in cash and cash equivalents before effect of exchange rate changes for the quarter ending 2023-06-30 was -$1.11B.
- Novartis AG increase decrease in cash and cash equivalents before effect of exchange rate changes for the quarter ending 2022-06-30 was -$10.18B, a 888.76% decline year-over-year.
| Period end | Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes 3 month | Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes 6 month | Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes 12 month |
|---|---|---|---|
| 2025-12-31 | -$600.00M 20-F · filed 2026-02-04 | ||
| 2025-06-30 | -$792.00M 6-K · filed 2025-07-17 | -$5.37B 6-K · filed 2025-07-17 | |
| 2024-12-31 | -$1.64B 20-F · filed 2026-02-04 | ||
| 2024-06-30 | -$1.53B 6-K · filed 2025-07-17 | -$5.33B 6-K · filed 2025-07-17 | |
| 2023-12-31 | $5.78B 20-F · filed 2026-02-04 | ||
| 2023-06-30 | -$1.11B 6-K · filed 2024-07-18 | $3.26B 6-K · filed 2024-07-18 | |
| 2022-12-31 | -$4.86B 20-F · filed 2025-01-31 | ||
| 2022-06-30 | -$10.18B 6-K · filed 2023-07-18 | -$8.69B 6-K · filed 2023-07-18 | |
| 2021-12-31 | $3.02B 20-F · filed 2024-01-31 | ||
| 2021-06-30 | $1.29B 6-K · filed 2022-07-19 | -$4.34B 6-K · filed 2022-07-19 | |
| 2020-12-31 | -$1.74B 20-F/A · filed 2023-05-15 | ||
| 2020-06-30 | $1.35B 6-K · filed 2021-07-21 | -$5.25B 6-K · filed 2021-07-21 | |
| 2019-12-31 | -$2.23B 20-F · filed 2022-02-02 | ||
| 2019-06-30 | $2.61B 6-K · filed 2020-07-21 | -$3.33B 6-K · filed 2020-07-21 | |
| 2018-12-31 | $4.44B 20-F · filed 2021-01-26 | ||
| 2018-06-30 | $6.74B 6-K · filed 2019-07-18 | $3.61B 6-K · filed 2019-07-18 | |
| 2017-12-31 | $1.77B 20-F · filed 2020-01-29 |